Science and Technology Questions for UPSC CSE

S&T Governance & Institutional Framework

India's S&T ecosystem is managed through multiple ministries and autonomous bodies. The Department of Science & Technology (DST) under MEYS handles basic research and innovation. The Department of Scientific & Industrial Research (DSIR) focuses on applied research and industry linkage. Science & Engineering Research Board (SERB) funds peer-reviewed research. The National Innovation Foundation (NIF) promotes grassroots innovation. This fragmented structure reflects India's attempt to balance academic research with industry needs—but coordination remains weak, a common exam critique.

• DST: basic research, innovation policy, technology missions (e.g., solar, water)
• DSIR: industrial R&D, technology transfer, CSIR labs (37 national labs)
• SERB: competitive research grants, peer review mechanism
• NIF: grassroots innovators, IP protection for traditional knowledge
• Ministry of Electronics & IT: semiconductors, digital infrastructure, cybersecurity

Key S&T Policies & Schemes (2014 onwards)

Post-2014, govt shifted focus from subsidies to innovation-led growth. Make in India (2014) aimed to position India as manufacturing hub. Startup India (2015) created tax incentives and IP fast-tracking. Atmanirbhar Bharat (2020) emphasized self-reliance in critical tech: semiconductors, pharma, medical devices, rare earths. National Research Foundation (2023) is the latest institutional push—consolidates research funding, mimics global models like NSF (USA). Each scheme reflects a policy shift: from import-dependent to self-reliant.

• Make in India: FDI attraction, manufacturing clusters, PLI schemes for electronics & pharma
• Startup India: 90-day patent examination, tax exemptions, fund-of-funds (SIDBI)
• Atmanirbhar Bharat: PLI for semiconductors, medical devices, battery manufacturing
• National Research Foundation (2023): unified research funding, 5-year grants, industry-academia tie-ups
• National Mission on Quantum Computing, AI: emerging tech priorities

R&D Spending & Global Comparison

India spends ~0.6-0.7% of GDP on R&D (GERD), far below OECD average of 2.4% and China's 2.1%. This is a persistent exam talking point. Most R&D is government-funded (60%+), unlike developed nations where industry drives it. CSIR labs consume bulk of budget but produce limited patents/commercialization. Examiners expect you to know: (1) why spending is low, (2) why private sector R&D is weak, (3) policy solutions (tax incentives, IP protection).

• India GERD: 0.6-0.7% of GDP vs China 2.1%, USA 2.8%, Germany 3.1%
• Government-funded R&D dominates; private sector R&D only 30-35% of total
• CSIR labs: 37 institutions, 4000+ scientists, but low patent commercialization rate
• Bottleneck: lack of venture capital, weak IP enforcement, brain drain
• Policy response: R&D tax credits (80-IC), SERB grants, startup incubation

Critical Technology Sectors

UPSC focuses on sectors where India has strategic interest or vulnerability. Semiconductors: India imports 100% of advanced chips; govt launched chip design clusters in Bangalore, Hyderabad. Artificial Intelligence: National AI Strategy (2021) targets healthcare, agriculture, smart cities. Biotechnology: India is pharma powerhouse but weak in biotech innovation; govt funds biotech parks. Renewable energy: India leads solar capacity but needs battery tech. Quantum computing: emerging frontier, NM-QC launched. Each sector has policy, challenges, and exam angles.

• Semiconductors: Design Linked Incentive scheme, fab incentives, ISRO-led initiatives
• AI: National AI Strategy, NASSCOM partnership, focus on agriculture & healthcare use cases
• Biotech: Biotech parks, gene therapy research, vaccine manufacturing (COVID lesson)
• Renewable Energy: Solar manufacturing, battery storage tech, green hydrogen
• Quantum: National Mission on Quantum Computing, IIT-Bombay, DRDO collaboration

Challenges & Reform Areas

Examiners love asking about bottlenecks. India's S&T system suffers from: (1) Regulatory delays—patent examination takes 4-5 years vs 2 years globally. (2) Weak industry-academia linkage—labs publish but don't commercialize. (3) Brain drain—top scientists emigrate. (4) Outdated IP laws—Design Act 2000 is weak. (5) Fragmented funding—multiple schemes, poor coordination. Recent reforms: Patent Amendment 2023 (faster examination), National Research Foundation (unified funding), PLI schemes (industry incentives). These are high-frequency Mains topics.

• Patent examination backlog: 15+ lakh pending applications; fast-track scheme helps but slow
• Low commercialization: CSIR patents rarely licensed; academia-industry gap
• Brain drain: ~50,000 Indian PhDs emigrate annually; visa policies, salary gaps
• Regulatory burden: FSSAI, DCGI approvals slow biotech/pharma innovation
• Fragmented funding: DST, DSIR, SERB, NRF overlap; poor inter-ministry coordination

Self-Reliance & Atmanirbhar Bharat Angle

Post-COVID, Atmanirbhar Bharat became central to S&T policy. Govt identified 6 critical sectors: semiconductors, active pharma ingredients (APIs), medical devices, rare earths, solar manufacturing, battery cells. PLI (Production Linked Incentive) scheme offers 4-6% subsidy on incremental sales. Goal: reduce import dependency, build domestic capacity. Exam angle: why self-reliance matters (supply chain resilience, geopolitics), what's working (Jio Platforms, Bharat Biotech), what's not (semiconductor fabs still pending). This is a 2023-24 hot topic.

• 6 critical sectors identified under Atmanirbhar Bharat for S&T
• PLI scheme: 4-6% incentive on incremental sales for 5 years
• Semiconductor fabs: ISMC (Bangalore), Micron (Gujarat) in pipeline; slow progress
• API manufacturing: CIPLA, Dr. Reddy's expanding; govt support for bulk drugs
• Geopolitical angle: Taiwan chip crisis, US-China tech war; India positioning as alternative

Intellectual Property & Innovation Ecosystem

IP protection is foundational to S&T growth. India's patent filing rate is low (~50,000/year vs China 1.5M), and enforcement is weak. Patent examination takes 4-5 years; courts are slow. However, India leads in pharma patents (generic drugs, incremental innovation). Recent reforms: Patent Amendment 2023 (faster examination, startup exemptions), Design Act modernization, Plant Variety Protection Act. Examiners test: why IP matters, India's IP ranking (42nd globally), what reforms help. This ties to startup ecosystem and Make in India.

• India patent filings: 50,000/year; examination backlog 15+ lakh; slow courts
• Pharma patents: India strong in generics, weak in novel drug discovery
• Recent reforms: Patent Amendment 2023, Design Act 2000 modernization, faster examination
• Startup IP: 90-day patent examination, fee waivers for startups under Startup India
• Global IP Index: India ranks 42nd (2023); goal is top 30 by 2030

• Confusing DST and DSIR roles: DST does basic research, DSIR does applied research and industry linkage. Many aspirants reverse this.
• Thinking India's R&D spending is low because govt doesn't fund enough: Actually, govt funds 60%+ but private sector R&D is weak. The problem is private sector, not public.
• Assuming PLI is a subsidy: PLI is performance-linked; companies get incentive only on incremental sales. It's conditional, not a blank check.
• Missing the geopolitical angle: UPSC Mains increasingly asks why semiconductors/AI matter for India's strategic autonomy. Generic answers about 'innovation' won't score.
• Forgetting institutional names: NRF (2023) is the latest big reform. Confusing it with older bodies like SERB or DST loses marks on current affairs.

• DST vs DSIR: Think 'D-ST = Discovery-Science-Theory' (basic), 'D-SIR = Discovery-Science-Industry-Realization' (applied).
• S&T Governance Pyramid: NRF (top, unified funding) > DST/DSIR (ministries) > CSIR/SERB (labs/grants) > Startups (grassroots).
• Atmanirbhar 6 Sectors: SPA-RBS = Semiconductors, Pharma APIs, Active pharma, Rare earths, Battery, Solar.
• R&D Spending Mnemonic: India 0.6% < China 2.1% < USA 2.8%. Remember '0-2-3' as rough ladder.
• Patent Exam Bottleneck: 4-5 years in India vs 2 years globally. Phrase: 'India's patent queue is 2x slower than world average.'

• Prelims: Expect 2-3 Qs on institutional roles (DST vs DSIR), scheme names (PLI, Startup India), or R&D spending comparisons. Factual, not analytical.
• Mains: 1-2 Qs typically ask 'What are India's S&T challenges and how can policy address them?' or 'Evaluate Atmanirbhar Bharat's S&T strategy.' Answer structure: (1) Current state, (2) Bottlenecks, (3) Policy solutions, (4) Global comparison. Use data (0.6% R&D spend, patent backlog) to strengthen.
• Current Affairs Hook: NRF (2023), Patent Amendment 2023, semiconductor fabs, AI strategy—these are recent and likely to appear. Link to Mains essay on 'Self-reliant India' or 'Innovation for growth.'
• Avoid Generic Answers: Don't just say 'India needs more R&D.' Specify: private sector R&D is weak (30% of total), patent examination is slow (4-5 years), brain drain is high (50k PhDs/year). Numbers impress.
• Geopolitical Framing: Always mention Taiwan chip crisis, US-China tech war, or supply chain resilience. UPSC values strategic thinking. E.g., 'Semiconductors matter because Taiwan supplies 60% of world chips; India must build capacity.'